Nathalie Criou, President of BeatSarcoma and Nathan Bossett, CFO, awarded Stanford University the first BeatSarcoma research gift. BeatSarcoma works closely with the medical community to identify under-funded high impact projects that will be conducted by leading non-profit research institutions. It favors fundamental and translational research as the funding needs there are greater and the benefits far-reaching.
'Stanford is a world-class institution that is home to several physicians nationally known for their understanding of sarcomas', says Nathalie Criou. 'when I first came to the Cancer Center for treatment, its team approach to sarcoma research and patient care had shown some great results.'
From left to right: Charlotte Jacobs, M.D., Nathan Bossett and Nathalie Criou
The current knowledge of sarcoma is so limited that specialists find it hard to issue accurate and timely diagnoses. This is an important first step toward effective treatment plans. It is one of the reasons why research efforts focusing on pathology can open the door to so many new developments.
One of the goals of the project coordinated at Stanford is to expand tumor tissue collection, banking and analysis of all types of sarcoma to help physicians better predict clinical outcomes.
Charlotte Jacobs, M.D., Drs Ben and A. Jess Shenson Professor of Medicine at Stanford University, says that 'sarcoma is a challenging disease that primarily affects people in the prime of their lives. It is also severely under-funded and research is still in its infancy. This gift from BeatSarcoma will enable the multi-disciplinary group of clinicians and researchers at Stanford to understand better the underlying pathology of the disease. In turn, this knowledge will help clinicians around the world make better treatment recommendations.'
To read more about the project, click here.
Post a Comment